Cortexyme Inc.(CRTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRTX Cortexyme Inc.

Pre-Mkt 12-15 05:02:49 EST

1.95

+0.00

0.00%

High1.95	Low1.95	Vol0.00
Open1.95	D1 Closing1.95	Amplitude0.00%
Mkt Cap70.49M	Tradable Cap48.29M	Total Shares36.15M
T/O521.88K	T/O Rate0.00%	Tradable Shares24.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRTX","market":"US","secType":"STK","nameCN":"Cortexyme Inc.","latestPrice":1.95,"timestamp":1659124800000,"preClose":1.95,"halted":8,"volume":0,"delay":0,"floatShares":24766297,"shares":36150835,"eps":-2.963495,"marketStatus":"Pre-Mkt","change":0,"latestTime":"12-15 05:02:49 EST","open":1.95,"high":1.95,"low":1.95,"amount":521880.71437500004,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.963495,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765809000000},"marketStatusCode":1,"symbolChange":{"newSymbol":"QNCX","executeDate":"2022-08-01"},"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":1.95,"volumeRatio":0},"requestUrl":"/m/hq/s/CRTX","defaultTab":"news","newsList":[{"id":"2254334192","title":"BRIEF-Cortexyme Corporate Name Change To Quince Therapeutics To Take Effect On August 1, 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2254334192","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2254334192?lang=en_us&edition=fundamental","pubTime":"2022-07-27 20:23","pubTimestamp":1658924583,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4512","LHDX","BK4082",".IXIC","SANA","BK4141","QLD","SQQQ","PSQ","TQQQ","APR","QQQ","BK4139","CGEM","QID","BK4007","BK4196","CRTX","QNCX","MNQmain","NQmain","ON","LABP"],"gpt_icon":0},{"id":"2234069489","title":"The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves","url":"https://stock-news.laohu8.com/highlight/detail?id=2234069489","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2234069489?lang=en_us&edition=fundamental","pubTime":"2022-05-10 21:23","pubTimestamp":1652188999,"startTime":"0","endTime":"0","summary":"Here&#39;s a roundup of top developments in the biotech space over the last 24 hours:","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/22/05/27104816/the-daily-biotech-pulse-pfizer-acquires-migraine-drug-maker-for-11b-biogen-files-for-second-alzhe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMUX","BHVN","OPNT","BK4581","URGN","AGEN","ATNX","ESALY","BMY","VERU","BIIB","BK4139","BK4550","CGEN","XENE","GMDA","RCUS","EXEL","AVIR","BAYRY","SYN","BK4532","RETA","ESALF","VERV","CALA","ZLAB","RVNC","CRTX","PFE","CERE","IBB","MYOV","BK4007","ZEAL","BK4568","PRAX","EVAX","LGVN","AVGR","IMTX","ARWR","BK4534","RUBY","CPRX","ITCI","BK4533"],"gpt_icon":0},{"id":"2234693244","title":"BRIEF-Cortexyme Announces Agreement To Acquire Novosteo","url":"https://stock-news.laohu8.com/highlight/detail?id=2234693244","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2234693244?lang=en_us&edition=fundamental","pubTime":"2022-05-10 20:09","pubTimestamp":1652184576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LABP","APR","BK4139","CGEM","LHDX","BK4007","ONTF","SANA","BK4196","CRTX","BK4082"],"gpt_icon":0},{"id":"2232761927","title":"BRIEF-Cortexyme - Co Is Further Reducing Headcount By 36%, Bringing Total Reduction To 67% From January 2022 Headcount Levels","url":"https://stock-news.laohu8.com/highlight/detail?id=2232761927","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2232761927?lang=en_us&edition=fundamental","pubTime":"2022-05-03 05:35","pubTimestamp":1651527311,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRTX","TSS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cortexyme.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease. Cortexyme, Inc. has a partnership with Parkinson Study Group. The company was incorporated in 2012 and is headquartered in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.089801},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.115491},{"month":3,"riseRate":0.666667,"avgChangeRate":0.129393},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.107118},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.075294},{"month":6,"riseRate":0.75,"avgChangeRate":0.19971},{"month":7,"riseRate":0.25,"avgChangeRate":-0.09049},{"month":8,"riseRate":0.666667,"avgChangeRate":0.122748},{"month":9,"riseRate":0.666667,"avgChangeRate":0.114958},{"month":10,"riseRate":0,"avgChangeRate":-0.355152},{"month":11,"riseRate":0.666667,"avgChangeRate":0.088233},{"month":12,"riseRate":0.333333,"avgChangeRate":0.226765}],"exchange":"NASDAQ","name":"Cortexyme Inc.","nameEN":"Cortexyme Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cortexyme Inc.(CRTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cortexyme Inc.(CRTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cortexyme Inc.,CRTX,Cortexyme Inc.股票,Cortexyme Inc.股票老虎,Cortexyme Inc.股票老虎国际,Cortexyme Inc.行情,Cortexyme Inc.股票行情,Cortexyme Inc.股价,Cortexyme Inc.股市,Cortexyme Inc.股票价格,Cortexyme Inc.股票交易,Cortexyme Inc.股票购买,Cortexyme Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cortexyme Inc.(CRTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cortexyme Inc.(CRTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}